Search Results

You are looking at 21 - 30 of 265 items for :

  • thyroglobulin x
Clear All
Emilio Fiore Department of Experimental and Clinical Medicine, Endocrinology Unit 1, University Hospital of Pisa, Pisa, Italy

Search for other papers by Emilio Fiore in
Google Scholar
PubMed
Close
,
Francesco Latrofa Department of Experimental and Clinical Medicine, Endocrinology Unit 1, University Hospital of Pisa, Pisa, Italy

Search for other papers by Francesco Latrofa in
Google Scholar
PubMed
Close
, and
Paolo Vitti Department of Experimental and Clinical Medicine, Endocrinology Unit 1, University Hospital of Pisa, Pisa, Italy

Search for other papers by Paolo Vitti in
Google Scholar
PubMed
Close

inducing thyroid autoimmunity is also strongly supported by animal models. Excessive iodine intake can precipitate spontaneous thyroiditis in genetically predisposed animals by increasing the immunogenicity of thyroglobulin (Tg) [ 21 ]. This may be

Free access
Germán A. Jimenez Londoño Nuclear Medicine Department, Hospital General Universitario de Ciudad Real, Ciudad Real, Spain

Search for other papers by Germán A. Jimenez Londoño in
Google Scholar
PubMed
Close
,
Ana Maria Garcia Vicente Nuclear Medicine Department, Hospital General Universitario de Ciudad Real, Ciudad Real, Spain

Search for other papers by Ana Maria Garcia Vicente in
Google Scholar
PubMed
Close
,
Julia Sastre Marcos Department of Endocrinology, Complejo Hospitalario de Toledo, Toledo, Spain

Search for other papers by Julia Sastre Marcos in
Google Scholar
PubMed
Close
,
Francisco Jose Pena Pardo Nuclear Medicine Department, Hospital General Universitario de Ciudad Real, Ciudad Real, Spain

Search for other papers by Francisco Jose Pena Pardo in
Google Scholar
PubMed
Close
,
Mariano Amo-Salas Department of Mathematics, University of Castilla-La Mancha, Ciudad Real, Spain

Search for other papers by Mariano Amo-Salas in
Google Scholar
PubMed
Close
,
Manuel Moreno Caballero Department of Nuclear Medicine, Hospital Universitario Infanta Cristina Badajoz, Badajoz, Spain

Search for other papers by Manuel Moreno Caballero in
Google Scholar
PubMed
Close
,
Maria Prado Talavera Rubio  Nuclear Medicine Department, Hospital General Universitario de Ciudad Real, Ciudad Real, Spain

Search for other papers by Maria Prado Talavera Rubio  in
Google Scholar
PubMed
Close
,
Beatriz Gonzalez Garcia Nuclear Medicine Department, Hospital General Universitario de Ciudad Real, Ciudad Real, Spain

Search for other papers by Beatriz Gonzalez Garcia in
Google Scholar
PubMed
Close
,
Niletys Dafne Disotuar Ruiz Nuclear Medicine Department, Hospital General Universitario de Ciudad Real, Ciudad Real, Spain

Search for other papers by Niletys Dafne Disotuar Ruiz in
Google Scholar
PubMed
Close
, and
Angel Maria Soriano Castrejón Nuclear Medicine Department, Hospital General Universitario de Ciudad Real, Ciudad Real, Spain

Search for other papers by Angel Maria Soriano Castrejón in
Google Scholar
PubMed
Close

patient based on the response to initial therapy (excellent, indeterminate, biochemical incomplete and structural incomplete response) using Preablation thyroglobulin (pTg), preablation AntiTg antibodies (pAntiTgAb), ultrasonography (US), diagnostic whole

Free access
Aamna Hassan Departments of Nuclear Medicine, Shaukat Khanum Memorial Cancer Hospital and Research Centre, Lahore, Pakistan

Search for other papers by Aamna Hassan in
Google Scholar
PubMed
Close
,
Saima Riaz Departments of Nuclear Medicine, Shaukat Khanum Memorial Cancer Hospital and Research Centre, Lahore, Pakistan

Search for other papers by Saima Riaz in
Google Scholar
PubMed
Close
,
Humayun Bashir Departments of Nuclear Medicine, Shaukat Khanum Memorial Cancer Hospital and Research Centre, Lahore, Pakistan

Search for other papers by Humayun Bashir in
Google Scholar
PubMed
Close
,
M. Khalid Nawaz Departments of Nuclear Medicine, Shaukat Khanum Memorial Cancer Hospital and Research Centre, Lahore, Pakistan

Search for other papers by M. Khalid Nawaz in
Google Scholar
PubMed
Close
, and
Raza Hussain Departments of Surgical Oncology, Shaukat Khanum Memorial Cancer Hospital and Research Centre, Lahore, Pakistan

Search for other papers by Raza Hussain in
Google Scholar
PubMed
Close

evidence of disease presence. Although the 18 F-fludeoxyglucose (FDG) PET/CT scan has a well-established role in detecting disease in RRD [ 1 ], the relation of the rate of thyroglobulin (Tg) rise or stimulated Tg level with the likelihood of disease

Free access
Solène Castellnou Hospices Civils de Lyon, Groupement Hospitalier Est, Fédération d’Endocrinologie, Bron, France

Search for other papers by Solène Castellnou in
Google Scholar
PubMed
Close
,
Patricia Bretones Service d’Endocrinologie Pédiatrique, Hospices Civils de Lyon, Groupement Hospitalier Est, Bron, France

Search for other papers by Patricia Bretones in
Google Scholar
PubMed
Close
,
Juliette Abeillon Hospices Civils de Lyon, Groupement Hospitalier Est, Fédération d’Endocrinologie, Bron, France

Search for other papers by Juliette Abeillon in
Google Scholar
PubMed
Close
,
Myriam Moret Hospices Civils de Lyon, Groupement Hospitalier Est, Fédération d’Endocrinologie, Bron, France

Search for other papers by Myriam Moret in
Google Scholar
PubMed
Close
,
Pauline Perrin Centre de Biologie et de Pathologie Est, Hospices Civils de Lyon, Groupement Hospitalier Est, LBMMS, Bron, France

Search for other papers by Pauline Perrin in
Google Scholar
PubMed
Close
,
Karim Chikh Centre de Biologie et de Pathologie Sud, Hospices Civils de Lyon, Groupement Hospitalier Sud, LBMMS, Saint Genis Laval, France

Search for other papers by Karim Chikh in
Google Scholar
PubMed
Close
, and
Véronique Raverot Centre de Biologie et de Pathologie Est, Hospices Civils de Lyon, Groupement Hospitalier Est, LBMMS, Bron, France

Search for other papers by Véronique Raverot in
Google Scholar
PubMed
Close

the reference range (<1.75 IU/L). Anti-thyroglobulin antibodies were less than 25 IU/mL (reference range <115) and thyroglobulin level was 9.4 µg/L (reference range 3.5–77). The thyroid gland was eutopic with a normal size on cervical ultrasonography

Free access
Jiahui Wu Arnie Charbonneau Cancer Institute, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada

Search for other papers by Jiahui Wu in
Google Scholar
PubMed
Close
,
Xunyang Hu Department of Medicine, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada

Search for other papers by Xunyang Hu in
Google Scholar
PubMed
Close
,
Paula Seal EFW Radiology, Calgary, Alberta, Canada
Department of Radiology, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada

Search for other papers by Paula Seal in
Google Scholar
PubMed
Close
,
Parthiv Amin Department of Radiology, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada

Search for other papers by Parthiv Amin in
Google Scholar
PubMed
Close
,
Brendan Diederichs Department of Radiology, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada
Mayfair Radiology, Calgary, Alberta, Canada

Search for other papers by Brendan Diederichs in
Google Scholar
PubMed
Close
, and
Ralf Paschke Section of Endocrinology, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada
Departments of Medicine, Oncology, Pathology and Laboratory Medicine, Biochemistry and Molecular Biology, and Arnie Charbonneau Cancer Institute, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada

Search for other papers by Ralf Paschke in
Google Scholar
PubMed
Close

Introduction Current postoperative follow-up (FU) and dynamic response to treatment (RTT) assessment of thyroid cancer primarily depends on postoperative neck ultrasound (POU) and thyroglobulin (Tg) determination ( 1 ). This FU strategy is

Open access
Tanvir Rizvi Nuclear Medicine Division, Department of Radiology and Medical Imaging, University of Virginia Health System, Charlottesville, Va., USA

Search for other papers by Tanvir Rizvi in
Google Scholar
PubMed
Close
and
Patrice K. Rehm Nuclear Medicine Division, Department of Radiology and Medical Imaging, University of Virginia Health System, Charlottesville, Va., USA

Search for other papers by Patrice K. Rehm in
Google Scholar
PubMed
Close

What Is Known about This Topic • Thyrogen® is commonly used for serum thyroglobulin testing, for radioiodine ( 131 I) imaging in those patients unwilling to undergo thyroid hormone withdrawal, in patients unable to mount an adequate thyroid

Free access
Fahim U. Hassan Nuclear Medicine Department, Borough Wing, Guy's Hospital, London, UK

Search for other papers by Fahim U. Hassan in
Google Scholar
PubMed
Close
and
Hosahalli K. Mohan Nuclear Medicine Department, Borough Wing, Guy's Hospital, London, UK

Search for other papers by Hosahalli K. Mohan in
Google Scholar
PubMed
Close

a large majority of patients. Follow-up is life-long with thyroid-stimulating hormone (TSH) suppression and thyroglobulin monitoring. Imaging plays a vital role in the detection, diagnosis, accurate staging and optimal management of patients with

Free access
Yasuhiro Ito Department of Surgery, Kuma Hospital, Shimoyamate-dori, Chuo-ku, Kobe, Hyogo, Japan

Search for other papers by Yasuhiro Ito in
Google Scholar
PubMed
Close
and
Akira Miyauchi Department of Surgery, Kuma Hospital, Shimoyamate-dori, Chuo-ku, Kobe, Hyogo, Japan

Search for other papers by Akira Miyauchi in
Google Scholar
PubMed
Close

persistent disease among those with PTC who underwent total thyroidectomy and were younger than 40 years or older than 60 years; however, only the latter group had a short thyroglobulin-doubling time ( 9 ). This finding is consistent with the fact that

Open access
Henry Völzke Institute for Community Medicine, University Medicine Greifswald, Greifswald, Germany

Search for other papers by Henry Völzke in
Google Scholar
PubMed
Close
,
Iris Erlund Department of Public Health Solutions, National Institute for Health and Welfare (THL), Helsinki, Finland

Search for other papers by Iris Erlund in
Google Scholar
PubMed
Close
,
Alicja Hubalewska-Dydejczyk Department of Endocrinology, Jagiellonian University Medical College, Krakow, Poland

Search for other papers by Alicja Hubalewska-Dydejczyk in
Google Scholar
PubMed
Close
,
Till Ittermann Institute for Community Medicine, University Medicine Greifswald, Greifswald, Germany

Search for other papers by Till Ittermann in
Google Scholar
PubMed
Close
,
Robin P. Peeters Department of Internal Medicine, Rotterdam Thyroid Centre, Erasmus Medical Centre, Rotterdam, The Netherlands

Search for other papers by Robin P. Peeters in
Google Scholar
PubMed
Close
,
Margaret Rayman University of Surrey, Surrey, United Kingdom

Search for other papers by Margaret Rayman in
Google Scholar
PubMed
Close
,
Monika Buchberger Department of Public Health and Health Technology Assessment, UMIT, University for Health Science, Medical Informatics and Technology, Hall, Austria

Search for other papers by Monika Buchberger in
Google Scholar
PubMed
Close
,
Uwe Siebert Department of Public Health and Health Technology Assessment, UMIT, University for Health Science, Medical Informatics and Technology, Hall, Austria

Search for other papers by Uwe Siebert in
Google Scholar
PubMed
Close
,
Betina H. Thuesen Research Centre for Prevention and Health, Glostrup, Denmark

Search for other papers by Betina H. Thuesen in
Google Scholar
PubMed
Close
,
Michael B. Zimmermann Swiss Federal Institute of Technology, Zürich Department of Health Sciences and Technology, Zürich, Switzerland

Search for other papers by Michael B. Zimmermann in
Google Scholar
PubMed
Close
,
Stefan Grünert Biolution GmbH, Vienna, Austria

Search for other papers by Stefan Grünert in
Google Scholar
PubMed
Close
, and
John H. Lazarus Institute of Molecular Medicine, Cardiff University, Cardiff, United Kingdom

Search for other papers by John H. Lazarus in
Google Scholar
PubMed
Close

building for harmonized IDD prevention and monitoring, including assessment of thyroglobulin (Tg) as an innovative and cost-effective biomarker of iodine status in individuals and populations; 4. Evaluation of Tg in pregnant women as a biomarker for

Free access
Anne-Sophie Bertrand Department of Interventional Radiology Imaging, Antoine Lacassagne Cancer Research Center, Nice, France

Search for other papers by Anne-Sophie Bertrand in
Google Scholar
PubMed
Close
,
Antoine Iannessi Department of Interventional Radiology Imaging, Antoine Lacassagne Cancer Research Center, Nice, France

Search for other papers by Antoine Iannessi in
Google Scholar
PubMed
Close
,
Isabelle Peyrottes Department of Anatomopathology, Antoine Lacassagne Cancer Research Center, Nice, France

Search for other papers by Isabelle Peyrottes in
Google Scholar
PubMed
Close
,
Alexis Lacout Department of Radiology, Centre médico-chirurgical ELSAN, Aurillac, France

Search for other papers by Alexis Lacout in
Google Scholar
PubMed
Close
,
Antoine Thyss Department of Oncology, Antoine Lacassagne Cancer Research Center, Nice, France

Search for other papers by Antoine Thyss in
Google Scholar
PubMed
Close
, and
Pierre-Yves Marcy Department of Interventional Radiology and Diagnostic Imaging, Polyclinique Les Fleurs Groupe ELSAN, Ollioules, France

Search for other papers by Pierre-Yves Marcy in
Google Scholar
PubMed
Close

histopathology specimen. No lymph node metastases were found. In June 2012, patient was administered radioactive treatment with iodine-131. Whole-body scintigram did not show any uptake foci; as serum thyroglobulin (Tg) level was still detectable (Tg = 10,5 ng

Free access